Exhibit 99.1

AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of Schedule 13G (including additional amendments thereto) with respect to the Common Stock, par value $0.000005 per share, of Precision BioSciences, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

Dated: March 26, 2025

	Readout Capital, LP
	Signature: /s/ Matthew Smith
	Name/Title: Matthew Smith/Manager, Readout Capital GP, LLC, its General Partner

	Readout Capital GP, LLC
	Signature: /s/ Matthew Smith
	Name/Title: Matthew Smith/Manager

	ROC Holdings SPV II, LP
	Signature: /s/ Matthew Smith
	Name/Title: Matthew Smith/Manager, Readout Holdings GP, LLC, its General Partner

	Readout Holdings GP, LLC
	Signature: /s/ Matthew Smith
	Name/Title: Matthew Smith/Manager

	Matthew Smith

	Signature: /s/ Matthew Smith
	Name/Title: Matthew Smith/Self

PRECISION BIOSCIENCES INC SCHEDULE 13G